alexa Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody Glomerulosclerosis Associated with Pulmonary Disorders

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody Glomerulosclerosis Associated with Pulmonary Disorders

Seven patients presented a specific renal lesion of rapidly progressive glomerulonephritis with myeloperoxidase anti-neutrophil cytoplasmic antibody. Rapidly progressive glomerulonephritis with myeloperoxidase anti-neutrophil cytoplasmic antibody can be associated with pulmonary hemorrhage and/or pulmonary interstitial fibrosis. The patients included three men and four women with a mean age of 62.4 years. All courses of renal lesions revealed rapidly progressive glomerulonephritis and the serum creatinine levels were 7.1 ± 3.9 mg/dl and the myeloperoxidase anti-neutrophil cytoplasmic antibody was 473 ± 471 EU before treatments. Steroid therapy was administered to all patients, immunosupressive agent to four and hemodialysis in six cases. Four patients experienced a pulmonary hemorrhage and died, but all of three patients with pulmonary interstitial fibrosis survived.

 

Citation: Sanai T, Hirakawa T, Mizumasa T, Koga H (2014) Myeloperoxidase Anti-neutrophil Cytoplasmic Antibody Glomerulosclerosis Associated with Pulmonary Disorders. J Steroids Hormon Sci 5:145. doi: 10.4172/2157-7536.1000145

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords